The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2024

Filed:

Jan. 20, 2020
Applicant:

Virginia Tech Intellectual Properties, Inc., Blacksburg, VA (US);

Inventors:

Michael B. Sano, Durham, NC (US);

Rafael V. Davalos, Blacksburg, VA (US);

John L Robertson, Floyd, VA (US);

Paulo A. Garcia, Cambridge, MA (US);

Robert E. Neal, Richmond, VA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61K 48/00 (2006.01); A61M 5/00 (2006.01); A61B 18/00 (2006.01); A61N 1/32 (2006.01);
U.S. Cl.
CPC ...
A61B 18/14 (2013.01); A61K 48/0075 (2013.01); A61M 5/00 (2013.01); A61B 2018/00613 (2013.01); A61B 2018/1472 (2013.01); A61B 18/1492 (2013.01); A61B 2218/002 (2013.01); A61N 1/327 (2013.01);
Abstract

The present invention relates to the field of medical treatment of diseases and disorders, as well as the field of biomedical engineering. Embodiments of the invention relate to the delivery of Irreversible Electroporation (IRE) through the vasculature of organs to treat tumors embedded deep within the tissue or organ, or to decellularize organs to produce a scaffold from existing animal tissue with the existing vasculature intact. In particular, methods of administering non-thermal irreversible electroporation (IRE) in vivo are provided for the treatment of tumors located in vascularized tissues and organs. Embodiments of the invention further provide scaffolds and tissues from natural sources created using IRE ex vivo to remove cellular debris, maximize recellularization potential, and minimize foreign body immune response. The engineered tissues can be used in methods of treating subjects, such as those in need of tissue replacement or augmentation.


Find Patent Forward Citations

Loading…